Pentwater Capital Management LP Catalent, Inc. Transaction History

Pentwater Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $227,200 - $371,300	5,000 New	5,000 $328,000
Q1 2021 May 17, 2021	SELL	$101.51 - $125.27 $497,399 - $613,823	-4,900 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $420,812 - $516,264	4,900 New	4,900 $510,000

16.8M

10.7K

53.4K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Pentwater Capital Management LP with notifications on news.